Karlheinz Peter

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 24

Top Venues

Arteriosclerosis, thrombosis, and vascular biology

Journal of the American Heart Association

British journal of pharmacology

European heart journal. Acute cardiovascular care

Alfred Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Alfred Hospital

Australia

Interventional Cardiologist

Publications

Nicole Garcia, Md Mostafizur Rahman, Carlos Luis Arellano, Ilia Banakh, Chen Yung-Chih, Karlheinz Peter, Heather Cleland, Cheng Hean Lo, Shiva Akbarzadeh
Graft-Host Interaction and Its Effect on Wound Repair Using Mouse Models. International journal of molecular sciences 24 (22) (2023)
Dong-Mei Wei, Jesus D Melgarejo, Lucas Van Aelst, Thomas Vanassche, Peter Verhamme, Stefan P Janssens, Karlheinz Peter, Zhen-Yu Zhang
Prediction of Coronary Artery Disease Using Urinary Proteomics. European journal of preventive cardiology (2023)
Himawan Fernando, Ziad Nehme, Catherine Milne, Jessica O'Brien, Stephen Bernard, Michael Stephenson, Paul S Myles, Jeffrey Lefkovits, Karlheinz Peter, Angela Brennan, Diem Dinh, Emily Andrew, Andrew J Taylor, Karen Smith, Dion Stub
LidocAine Versus Opioids In MyocarDial infarction: the AVOID-2 randomized controlled trial. European heart journal. Acute cardiovascular care 12 (1) (2023)
Mayra Alejandra Jaimes Campos, Iván Andújar, Felix Keller, Gert Mayer, Peter Rossing, Jan A Staessen, Christian Delles, Joachim Beige, Griet Glorieux, Andrew L Clark, William Mullen, Joost P Schanstra, Antonia Vlahou, Kasper Rossing, Karlheinz Peter, Alberto Ortiz Arduan, Archie I Campbell, Frederik Persson, Agnieszka Latosinska, Harald Mischak, Justyna Siwy, Joachim Jankowski
Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study. Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Aidan P G Walsh, Eefang Yu, James D McFadyen, Viktoria Bongcaron, Mitchell J Moon, Angela Huang, Jane Arthur, Ineke Muir, Veronika Rayzman, Con Panousis, Xiaowei Wang, Karlheinz Peter
Activated Coagulation FXII (Factor XII): A Unique Target for In Vivo Molecular Imaging. Arteriosclerosis, thrombosis, and vascular biology (2023)
Anna M D Watson, Yung-Chih Chen, Karlheinz Peter
Vascular Aging and Vascular Disease Have Much in Common! Arteriosclerosis, thrombosis, and vascular biology 42 (8) (2022)
Jiawen Li, Simon Thiele, Rodney W Kirk, Bryden C Quirk, Ayla Hoogendoorn, Yung Chih Chen, Karlheinz Peter, Stephen J Nicholls, Johan W Verjans, Peter J Psaltis, Christina A Bursill, Alois M Herkommer, Harald Giessen, Robert A McLaughlin
3D-Printed Micro Lens-in-Lens for In Vivo Multimodal Microendoscopy. Small (Weinheim an der Bergstrasse, Germany) 18 (17) (2022)
Berhe W Sahle, David V Pilcher, Karlheinz Peter, James D McFadyen, Tracey K Bucknall
Trends and risk factors for omission of early thromboprophylaxis in Australian and New Zealand ICUs between 2009 and 2020. Intensive care medicine 48 (5) (2022)
Himawan Fernando, Ziad Nehme, Catherine Milne, Jessica O'Brien, Stephen Bernard, Michael Stephenson, Paul S Myles, Jeffrey Lefkovits, Karlheinz Peter, Angela Brennan, Diem Dinh, Emily Andrew, Andrew J Taylor, Karen Smith, Dion Stub, null null
LidocAine Versus Opioids In MyocarDial infarction: The AVOID-2 randomised controlled trial. European heart journal. Acute cardiovascular care (2022)
Sourabh Mehta, Viktoria Bongcaron, Tien K Nguyen, Yugandhara Jirwanka, Ana Maluenda, Aidan P G Walsh, Jathushan Palasubramaniam, Mark D Hulett, Rohit Srivastava, Alex Bobik, Xiaowei Wang, Karlheinz Peter
An Ultrasound-Responsive Theranostic Cyclodextrin-Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis. Small (Weinheim an der Bergstrasse, Germany) 18 (31) (2022)
Gemma A Figtree, Philip D Adamson, Charalambos Antoniades, Roger Scott Blumenthal, Michael J Blaha, Matthew J Budoff, David S Celermajer, Mark Yan-Yee Chan, Clara Kayei Chow, Damini Dey, Girish Dwivedi, Nicola Giannotti, Stuart M Grieve, Christian R Hamilton-Craig, Bronwyn A Kingwell, Jason C Kovacic, James K Min, David E Newby, Sanjay Patel, Karlheinz Peter, Peter J Psaltis, Stephen T Vernon, Dennis T Wong, Stephen J Nicholls
Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development. Circulation 146 (22) (2022)
Johannes Zeller, Karen S Cheung Tung Shing, Tracy L Nero, James D McFadyen, Guy Krippner, Balázs Bogner, Sheena Kreuzaler, Jurij Kiefer, Verena K Horner, David Braig, Habiba Danish, Sara Baratchi, Mark Fricke, Xiaowei Wang, Michel G Kather, Bernd Kammerer, Kevin J Woollard, Prerna Sharma, Craig J Morton, Geoffrey Pietersz, Michael W Parker, Karlheinz Peter, Steffen U Eisenhardt
A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein. EMBO molecular medicine (2022)
Hannah Stevens, Rodrigo Cánovas, Huyen A Tran, Karlheinz Peter, James D McFadyen
Inherited Thrombophilias Are Associated With a Higher Risk of COVID-19-Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study. Circulation 145 (12) (2022)
Bianca Rocca, Karlheinz Peter
Platelets, coagulation, and the vascular wall: the quest to better understand and smarten up our therapeutic targeting of this triad in primary and secondary prevention of cardiovascular events. Cardiovascular research 117 (9) (2021)
Yung Chih Chen, Karin Agnes Maria Jandeleit-Dahm, Karlheinz Peter
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes-Induced Atherosclerotic Plaque Instability. Journal of the American Heart Association 11 (1) (2021)
James D McFadyen, Karlheinz Peter
The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopaenia. Cardiovascular research 117 (11) (2021)
Himawan Fernando, Thy Duong, Kevin Huynh, Jonathan Noonan, James A Shaw, Stephen J Duffy, Ziad Nehme, Karen Smith, Paul Stewart Myles, Peter J Meikle, Karlheinz Peter, Dion Stub
Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: the LOCAL trial. European heart journal 42 (39) (2021)
James D McFadyen, Prerna Sharma, Mitchell J Moon, Jonathan Noonan, Elizabeth Goodall, Huyen A Tran, Karlheinz Peter
Activation of circulating platelets in vaccine-induced thrombotic thrombocytopenia and its reversal by intravenous immunoglobulin. British journal of haematology (2021)
Mitchell J Moon, James D McFadyen, Karlheinz Peter
Caught at the Scene of the Crime: Platelets and Neutrophils Are Conspirators in Thrombosis. Arteriosclerosis, thrombosis, and vascular biology (2021)
Xiaowei Wang, Melanie Ziegler, James D McFadyen, Karlheinz Peter
Molecular imaging of arterial and venous thrombosis. British journal of pharmacology 178 (21) (2021)
Katharine A Kott, Marie-Christine Morel-Kopp, Stephen T Vernon, Yuki Takagi, Belinda A Di Bartolo, Karlheinz Peter, Jean Yee Hwa Yang, Stuart M Grieve, Christopher M Ward, Gemma A Figtree
Association of Global Coagulation Profiles With Cardiovascular Risk Factors and Atherosclerosis: A Sex Disaggregated Analysis From the BioHEART-CT Study. Journal of the American Heart Association 10 (20) (2021)
Austin Lai, Charles D Cox, Nadia Chandra Sekar, Peter Thurgood, Anthony Jaworowski, Karlheinz Peter, Sara Baratchi
Mechanosensing by Piezo1 and its implications for physiology and various pathologies. Biological reviews of the Cambridge Philosophical Society (2021)
Austin Lai, Yung Chih Chen, Charles D Cox, Anthony Jaworowski, Karlheinz Peter, Sara Baratchi
Analyzing the shear-induced sensitization of mechanosensitive ion channel Piezo-1 in human aortic endothelial cells. Journal of cellular physiology 236 (4) (2020)
Jonathan Noonan, Alex Bobik, Karlheinz Peter
The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture. British journal of pharmacology (2020)

Karlheinz Peter.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Karlheinz Peter